Westwood Holdings Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
NAMA
BCM
Westwood Holdings Group's TXG Position: Q3 2024 in Review
Westwood Holdings Group sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 47,974 shares — an estimated $933K sold.
Westwood Holdings Group first reported a position in TXG in Q1 2024 and held it in 2 quarters. The position peaked at $939K in Q1 2024. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.
- Westwood Holdings Group reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
- Westwood Holdings Group sold 47,974 10x Genomics shares in Q3 2024, an estimated $933K.
- Westwood Holdings Group first reported a position in 10x Genomics in Q1 2024 and held it in 2 quarters.
- Westwood Holdings Group's 10x Genomics position peaked at $939K in Q1 2024.
- 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.
Based on Westwood Holdings Group's 13F filing for Q3 2024, filed 14 Nov 2024.